Compare · head to head
KT & G vs Sino Biopharmaceutical
KT & G ranks higher overall — 360 rank 100 vs 55.
Sino Biopharmaceutical leads on Value (60 vs 50). KT & G leads on Quality (56 vs 42), Growth (76 vs 43), Safety (90 vs 57) and Sentiment (60 vs 53).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Hong Kong SAR China |
| Sector | Food, Drinks & Tobacco | Health Care |
| Industry | Tobacco | Pharmaceuticals |
| Size | Large | X-Large |
| ISIN | KR7033780008 | KYG8167W1380 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 100 | 55 |
| Value | 50 | 60 |
| Quality | 56 | 42 |
| Growth | 76 | 43 |
| Safety | 90 | 57 |
| Sentiment | 60 | 53 |
| Quality details | ||
| Profitability | 70 | 36 |
| Cash Truth | 42 | 48 |
KT & G vs Japan TobaccoKT & G vs Kaken PharmaceuticalKT & G vs HandokKT & G vs Green CrossAdd a third stock →
Full analyses: KT & G · Sino Biopharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100